Context It remains unclear whether patients with a suspicion of prostate cancer (PCa) and
negative multiparametric magnetic resonance imaging (mpMRI) can safely obviate prostate …

High-quality evidence shows that MRI in biopsy-naive men can reduce the number of men
who need prostate biopsy and can reduce the number of diagnoses of clinically insignificant …

BACKGROUND The current study was conducted to evaluate the performance of magnetic
resonance (MR)‐ultrasound‐guided fusion biopsy in diagnosing clinically significant …

Background Multiparametric magnetic resonance imaging (mpMRI) of the prostate has
excellent sensitivity in detecting clinically significant prostate cancer (csPCa). Nevertheless …

Imaging has traditionally played a minor role in the diagnosis and staging of prostate cancer.
However, recent controversies generated by the use of prostate‐specific antigen (PSA) …

Objectives To identify areas of agreement and disagreement in the implementation of multi‐
parametric magnetic resonance imaging (mp MRI) of the prostate in the diagnostic pathway …

Multiparametric-magnetic resonance imaging (mp-MRI) has shown promising results in
diagnosis, localization, risk stratification and staging of clinically significant prostate cancer …

Objectives To evaluate the cancer detection rates for men undergoing 12‐core systematic
prostate biopsy with negative prebiopsy multiparametric magnetic resonance imaging (mp …

An increase or 'upgrade'in Gleason Score (GS) in prostate cancer following Transrectal
Ultrasound (TRUS) guided biopsies remains a significant challenge to overcome. to …

Purpose Following a prostate cancer diagnosis, patients are faced with a multitude of care
options, the advisability of which is influenced by patient factors and by cancer severity or …